SEARCH

SEARCH BY CITATION

References

  • Agarwala, S., A. K. Hemal, S. Seth, A. K. Gupta, V. Bhatnagar & D. K. Mitra: Transitional cell carcinoma of the urinary bladder following exposure to cyclophosphamide in childhood. Eur. J. Pediatr. Surg. 2001, 11, 207210.
  • Agrawal, R. C. & S. Kumar: Prevention of cyclophosphamide-induced micronucleus formation in mouse bone marrow by indole-3-carbinol. Food Chem. Toxicol. 1998, 36, 975977.
  • Attele, A. S., J. A. Wu & C. S. Yuan: Ginseng pharmacology. Biochem. Pharmacol. 1999, 58, 16851693.
  • Bae, E. A., M. J. Han & E. J. Kim: Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch. Pharm. Res. 2004, 27, 6167.
  • Ben-Hur, E. & S. Fulder: Effect of Panax ginseng saponins and Eleutherococcus senticosus on survival of cultured mammalian cells after ionizing radiation. Amer. J. Chin. Med. 1981, 9, 4856.
  • Chang, Y. S., E. K. Seo, C. Gyllenhaal & K. I. Block: Panax ginseng: a role in cancer therapy? Integr. Cancer Ther. 2003, 2, 1333.
  • Chen, Y. P., Q. Meng, C. C. Song, X. Y. Ma, G. S. Wang & J. D. Xu: Preparation of 20(S)-protopanaxadiol saponins and 20(S)-ginsenoside Rh2 from 20(S)-protopanaxadiol saponins. Chin. Pharm. J. 1997, 32, 273275.
  • Cheng, C. C., S. M. Yang, C. Y. Huang, J. C. Chen, W. M. Chang & S. L. Hsu: Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother. Pharmacol. 2005, 55, 531540.
  • Franke, S. I., D. Pra, J. Da Silva, B. Erdtmann & J. A. Henriques: Possible repair action of Vitamin C on DNA damage induced by methyl methanesulfonate, cyclophosphamide, FeSO4 and CuSO4 in mouse blood cells in vivo. Mutat. Res. 2005, 583, 7584.
  • Habs, M. R. & D. Schmahl: Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2′-dithio-bis-ethane sulfonate (dimesna). Cancer 1983, 51, 606609.
  • Heller, A., V. Trifonov, N. Rubtsov, A. Sauerbrey, H. Starke, I. F. Loncarevic, U. Claussen & T. Liehr: Complex chromosomal rearrangements in a secondary acute myeloblastic leukemia after chemotherapy in TRAPS. Oncol. Rep. 2003, 10, 17891792.
  • Helms, S.: Cancer prevention and therapeutics: Panax ginseng. Altern. Med. Rev. 2004, 9, 259274.
  • Jenderny, J., R. A. Walk, U. Hackenberg & G. Rohrborn: Chromosomal abnormalities and sister-chromatic exchange in bone marrow cells of mice and Chinese hamsters after inhalation and intraperitoneal administration. II. Cyclophosphamide. Mutat. Res. 1988, 203, 110.
  • Jia, W. W., X. Bu, D. Philips, H. Yan, G. Liu, X. Chen, J. A. Bush & G. Li: Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy. Can. J. Physiol. Pharmacol. 2004, 82, 431437.
  • Kaldor, J. M., N. E. Day, A. Clarke, F. E. Van Leeuwen, M. Henry-Amar, M. V. Fiorentino, J. Bell, D. Pedersen, P. Band & D. Assouline: Leukemia following Hodgkin's disease. New Engl. J. Med. 1990, 322, 713.
  • Keum, Y. S., S. S. Han, K. S. Chun, K. K. Park, J. H. Park, S. K. Lee & Y. J. Surh: Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-κB activation and tumor promotion. Mutat. Res. 2003, 523, 7585.
  • Kim, Y. S., D. S. Kim & S. I. Kim: Gensenoside Rh2 and Rh3 induce differentiation of HL-60 cells into granulocytes: modulation of protein kinase C isoforms during differentiation by ginsenoside Rh2. Int. J. Biochem. Cell Biol. 1998, 30, 327338.
  • Kim, Y. S. & S. H. Jin: Ginsenoside Rh2 induces apoptosis via activation of caspase-1 and -3 and up-regulation of Bax in human neuroblastoma. Arch. Pharm. Res. 2004, 27, 834839.
  • Konca, K., A. Lankoff, A. Banasik, H. Lisowska, T. Kuszewski, S. Gozdz, Z. Koza & A. Wojcik: A cross-platform public domain PC image-analysis program for the comet assay. Mutat. Res. 2003, 534, 1520.
  • Lee, H. U., E. A. Bae, M. J. Han & D. H. Kim: Hepatoprotective effect of 20(S)-ginsenoside Rg3 and its metabolite 20(S)-ginsenoside Rh2 on tert-butyl hydroperoxide-induced liver injury. Bio. Pharm. Bull. 2005, 28, 19921994.
  • Lee, T. K., R. R. Allison, K. F. O'Brien, H. Lisowska, T. Kuszewski, S. Gozdz, Z. Koza & A. Wojcik: Ginseng reduces the micronuclei yield in lymphocytes after irradiation. Mutat. Res. 2004, 557, 7584.
  • Levine, E. G. & C. D. Bloomfield: Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Sem. Oncol. 1992, 19, 4784.
  • Liu, W. K., S. X. Xu & C. T. Che: Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci. 2000, 67, 12971306.
  • Manda, K. & A. L. Bhatia: Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice. Cell Biol. Toxicol. 2003, 19, 367372.
  • Nakata, H., Y. Kikuchi, T. Tode, J. Hirata, T. Kita, K. Ishii, K. Kudoh, I. Nagata & N. Shinomiya: Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jap. J. Cancer Res. 1998, 89, 733740.
  • Ong, Y. C. & E. L. Yong: Panax (Ginseng) – panacea or placebo? Molecular and cellular basis of its pharmacological activity. Ann. Acad. Med. Singapore 2000, 29, 4246.
  • Panwar, M., M. Kumar, R. Samarth & A. Kumar: Evaluation of chemopreventive action and antimutagenic effect of the standardized Panax ginseng extract, EFLA400, in Swiss albino mice. Phytother. Res. 2005, 19, 6571.
  • Rohn, T. T., T. R. Hinds & F. F. Vincenzi: Inhibition of the Ca pump of intact red blood cells by t-butyl hydroperoxide: importance of glutathione peroxidase. Biochim. Biophys. Acta 1993, 1153, 6776.
  • Salvia, R. D., M. Fiore, T. Aglitti, F. Festa, R. Ricordy & R. Cozzi: Inhibitory action of melatonin on H2O2- and cyclophosphamide-induced DNA damage. Mutagenesis 1999, 14, 107112.
  • Schmid, W.: The micronucleus test. In: Chemical mutagens, principles and methods for their detection. Ed.: A.Hollaender. Plenum Press, New York, USA, 1976, pp. 31.
  • Tatsuka, M., M. Maeda & T. Ota: Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh(2). Jap. J. Cancer Res. 2001, 92, 11841189.
  • Yokoyama, Y., M. Futagami, M. Fukushi, T. Sakamoto, T. Higuchi, S. Fujii, S. Sato, H. Takami & Y. Saito: Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer. Arch. Gynecol. Obstet. 2000, 263, 206207.
  • Zeng, X. L. & Z. G. Tu: In vitro induction of differentiation by ginsenoside Rh2 in SMMC-7721 hepatocarcinoma cell line. Pharmacology & Toxicology 2003, 93, 275283.
  • Zhu, J. H., T. Takeshita, I. Kitagawa & K. Miromoto: Suppression of the formation of sister chromatic exchanges by low concentrations of ginsenoside Rh2 in human blood lymphocytes. Cancer Res. 1995, 55, 12211223.